市場調査レポート
商品コード
1640757

水分関連皮膚損傷管理市場:世界の産業分析、市場規模・シェア・成長・動向、将来予測 (2025~2032年)

Moisture-associated Skin Damage Management Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032


出版日
ページ情報
英文 188 Pages
納期
2~5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
水分関連皮膚損傷管理市場:世界の産業分析、市場規模・シェア・成長・動向、将来予測 (2025~2032年)
出版日: 2025年01月17日
発行: Persistence Market Research
ページ情報: 英文 188 Pages
納期: 2~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界の水分関連皮膚損傷 (MASD) 管理の市場に関する包括的な分析を発表しました。当レポートでは、市場促進要因・動向・機会・課題などの重要な市場力学を徹底的に評価し、市場構造に関する詳細な洞察を提供しています。当レポートは、世界のMASD管理市場の予測成長軌道 (2025~2032年) を概説する独占的データと統計を掲載しています。

主要な洞察

  • MASD管理の市場規模 (2025年):44億米ドル
  • 市場規模の予測 (金額ベース、2032年):68億米ドル
  • 世界市場の成長率 (CAGR、2025~2032年):6.5%

水分関連皮膚損傷管理市場:分析範囲

水分関連皮膚障害とは、多くの場合、失禁や汗に長時間さらされることによる過剰な水分によって引き起こされる皮膚の損傷を指します。MASD管理は、様々な医療機器、製品、治療を通じて、このような皮膚状態の予防、診断、治療に焦点を当てています。MASD管理市場は、病院、医療センター、長期介護施設、在宅介護の現場に対応し、バリアクリーム、吸収パッド、高度創傷被覆材などの製品を提供しています。水分ダメージに関連する皮膚疾患の有病率の増加と高齢化人口の増加が市場成長の主な促進要因です。

市場成長の促進要因:

世界のMASD管理市場は、MASDに対する認識の高まりや患者のQOLへの影響など、いくつかの重要な要因によって推進されています。高齢化社会における失禁や関連する皮膚疾患の発生率の増加が、効果的な管理ソリューションに対する需要をさらに押し上げています。さらに、医療製品の進歩や、より効率的な創傷ケアやバリア治療の開発は、患者の転帰や快適性の向上に寄与しています。MASDのモニタリングと管理のための在宅ケア環境の拡大とデジタルヘルス技術の採用も、市場成長の新たな機会を生み出しています。

市場の抑制要因:

有望な成長見通しにもかかわらず、MASD管理市場は、MASD治療に対する償還範囲の制限や高度創傷ケア製品の高価格といった課題に直面しています。規制上のハードルや、特に長期療養施設における複数の合併症を持つ患者の管理の複雑さも、医療プロバイダーやメーカーに課題を突きつけています。地域によっては治療プロトコールが標準化されていないため、効果的なMASD管理ソリューションの普及がさらに困難になる可能性があります。

市場機会:

MASD管理市場は、技術革新、人口動向、進化する医療提供モデルによって大きな成長機会がもたらされます。カスタマイズされた創傷ケア用ドレッシング材やバリア製品など、患者に特化した製品の開発は、市場参入者にとって重要な機会となります。さらに、遠隔医療プラットフォームと皮膚状態の遠隔モニタリングなどのデジタルヘルス技術の統合は、MASD管理ソリューションへのアクセシビリティを高め、治療のアドヒアランスを向上させます。戦略的パートナーシップ、研究開発への投資、費用対効果が高くユーザーフレンドリーな製品のイントロダクションは、こうした機会を活用し、市場でのリーダーシップを維持するために不可欠です。

当レポートで回答する主な質問

  • MASD管理市場の世界の成長を促進する主な要因は何か?
  • さまざまな医療環境でMASD管理に最もよく使用されている製品や治療法は何か?
  • 技術進歩はMASD管理市場の競合情勢をどのように形成しているか?
  • MASD管理市場の主要企業はどこか?また、市場の関連性を維持するためにどのような戦略をとっているのか?
  • 世界のMASD管理市場における新たな動向と将来展望は?

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
    • 主な動向
  • マクロ経済要因
    • 世界のGDP成長見通し
    • 世界の医療費の見通し
  • COVID-19の影響分析
  • 予測要因:関連性と影響

第3章 付加価値分析

  • 規制状況
  • 製品採用分析
  • 主要な取引と合併
  • MASDの製品カテゴリーの比較
  • PESTLE分析
  • ポーターのファイブフォース分析

第4章 世界の水分関連皮膚損傷管理市場の展望:過去 (2019~2023年) と予測 (2025~2032年)

  • 主なハイライト
    • 市場規模と前年比成長率 (金額ベース (10億米ドル))
    • 絶対的収益機会
  • 市場規模の分析と予測 (金額ベース (10億米ドル))
    • 過去の市場規模の分析 (金額ベース (10億米ドル)、2019~2023年)
    • 現在の市場規模の分析・予測 (金額ベース (10億米ドル)、2025~2032年)
  • 世界の水分関連皮膚損傷管理市場の展望:製品別
    • イントロダクション/主な調査結果
    • 過去の市場規模の分析:製品別 (金額ベース (10億米ドル)、2019~2023年)
    • 現在の市場規模の分析と予測:製品別 (金額ベース (10億米ドル)、2025~2032年)
      • ワセリンベースのバリア
      • 酸化亜鉛ベースのバリア
      • シリコン系バリア
      • シアノアクリレート-ポリマーフィルムバリア
      • BCTエージェント
    • 市場魅力分析:製品別
  • 世界の水分関連皮膚損傷管理市場の展望:形状別
    • イントロダクション/主な調査結果
    • 過去の市場規模の分析:形状別 (金額ベース (10億米ドル)、2019~2023年)
    • 現在の市場規模の分析と予測:形状別 (金額ベース (10億米ドル)、2025~2032年)
      • ゲル
      • クリーム
      • ローション
      • 軟膏
      • その他
    • 市場魅力分析:形状別
  • 世界の水分関連皮膚損傷管理市場の展望:適応症別
    • イントロダクション/主な調査結果
    • 過去の市場規模の分析:適応症別 (金額ベース (10億米ドル)、2019~2023年)
    • 現在の市場規模の分析と予測:適応症別 (金額ベース (10億米ドル)、2025~2032年)
      • ストーマ周囲湿気関連皮膚炎
      • 創傷周囲の湿気による皮膚炎
      • 失禁関連皮膚炎
      • 間擦性皮膚炎
      • 浸水足 (塹壕足)
    • 市場魅力分析:適応症別
  • 世界の水分関連皮膚損傷管理市場の展望:流通チャネル別
    • イントロダクション/主な調査結果
    • 過去の市場規模の分析:流通チャネル別 (金額ベース (10億米ドル)、2019~2023年)
    • 現在の市場規模の分析と予測:流通チャネル別 (金額ベース (10億米ドル)、2025~2032年)
      • 小売薬局・ドラッグストア
      • 診療所・病院薬局
      • オンライン薬局
    • 市場魅力分析:流通チャネル別

第5章 世界の水分関連皮膚損傷管理市場の展望:地域別

  • 主なハイライト
  • 過去の市場規模の分析:地域別 (金額ベース (10億米ドル)、2019~2023年)
  • 現在の市場規模の分析と予測:地域別 (金額ベース (10億米ドル)、2025~2032年)
    • 北米
    • 欧州
    • 東アジア
    • 南アジア・オセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析:地域別

第6章 北米の水分関連皮膚損傷管理市場の展望:過去 (2019~2023年) と予測 (2025~2032年)

第7章 欧州の水分関連皮膚損傷管理市場の展望:過去 (2019~2023年) と予測 (2025~2032年)

第8章 東アジアの水分関連皮膚損傷管理市場の展望:過去 (2019~2023年) と予測 (2025~2032年)

第9章 南アジア・オセアニアの水分関連皮膚損傷管理市場の展望:過去 (2019~2023年) と予測 (2025~2032年)

第10章 ラテンアメリカの水分関連皮膚損傷管理市場の展望:過去 (2019~2023年) と予測 (2025~2032年)

第11章 中東・アフリカの水分関連皮膚損傷管理市場の展望:過去 (2019~2023年) と予測 (2025~2032年)

第12章 競合情勢

  • 市場シェア分析 (2023年)
  • 市場構造
    • 競合激化マップ:市場別
    • 競合ダッシュボード
  • 企業プロファイル (詳細:概要、財務、戦略、最近の動向)
    • 3M
    • Medline Industries, Inc.
    • Dynarex Corporation
    • Coloplast Corp.
    • Wellona Pharma
    • Cardinal Health
    • Stryker Sage (Stryker)
    • DermaRite Industries, LLC.
    • AMERX Health Care Corp.
    • Calmoseptine, Inc.
    • PAUL HARTMANN AG
    • Smith+Nephew, Inc.
    • Gentell
    • UNIFARCO SpA
    • Others

第13章 付録

  • 分析手法
  • 分析の前提条件
  • 頭字語と略語
目次
Product Code: PMRREP29518

Persistence Market Research has recently released a comprehensive report on the worldwide market for Moisture-associated Skin Damage (MASD) management. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global MASD management market from 2025 to 2032.

Key Insights:

  • MASD Management Market Size (2025E): US$ 4.4 Bn
  • Projected Market Value (2032F):US$ 6.8 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.5%

Moisture-associated Skin Damage Management Market - Report Scope:

Moisture-associated Skin Damage refers to skin injury caused by excessive moisture, often due to incontinence or prolonged exposure to sweat. MASD management focuses on the prevention, diagnosis, and treatment of such skin conditions through various medical devices, products, and therapies. The MASD management market caters to hospitals, healthcare centers, long-term care facilities, and homecare settings, offering products such as barrier creams, absorbent pads, and advanced wound dressings. The increasing prevalence of skin conditions associated with moisture damage and the rising aging population are key drivers of market growth.

Market Growth Drivers:

The global MASD management market is propelled by several key factors, including the growing awareness of MASD and its impact on patients' quality of life. The increasing incidence of incontinence and related skin conditions among the aging population further drives the demand for effective management solutions. Moreover, advancements in medical products and the development of more efficient wound care and barrier treatments contribute to enhanced patient outcomes and comfort. The expansion of homecare settings and the adoption of digital health technologies for monitoring and managing MASD also create new opportunities for market growth.

Market Restraints:

Despite promising growth prospects, the MASD management market faces challenges such as limited reimbursement coverage for MASD treatments and the high cost of advanced wound care products. Regulatory hurdles and the complexity of managing patients with multiple comorbidities, especially in long-term care facilities, also pose challenges for healthcare providers and manufacturers. The lack of standardized treatment protocols in some regions may further complicate the widespread adoption of effective MASD management solutions.

Market Opportunities:

The MASD management market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The development of patient-specific products, including customized wound care dressings and barrier products, represents a key opportunity for market players. Furthermore, the integration of telemedicine platforms and digital health technologies, such as remote monitoring of skin conditions, enhances the accessibility of MASD management solutions and improves treatment adherence. Strategic partnerships, investment in R&D, and the introduction of cost-effective and user-friendly products are essential to capitalize on these opportunities and sustain market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the MASD management market globally?
  • Which products and therapies are most commonly used in managing MASD across different healthcare settings?
  • How are technological advancements shaping the competitive landscape of the MASD management market?
  • Who are the key players contributing to the MASD management market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global MASD management market?

Competitive Intelligence and Business Strategy:

Leading players in the global MASD management market, including Coloplast, ConvaTec, and Molnlycke Health Care, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest heavily in R&D to develop advanced wound care solutions, barrier products, and digital health integration for enhanced MASD management. Collaborations with healthcare providers, insurance companies, and regulatory bodies are key strategies to overcome market barriers and expand their customer base. Emphasis on clinical research, evidence-based practices, and patient education fosters market growth and improves patient outcomes.

Key Companies Profiled:

  • Coloplast
  • ConvaTec
  • Molnlycke Health Care
  • Smith & Nephew
  • 3M
  • Hollister Incorporated
  • Medline Industries, Inc.
  • Kimberly-Clark Health Care
  • DermaRite Industries, LLC
  • Acelity Inc.

Moisture-associated Skin Damage Management Market Segmentation

By Product

  • Petrolatum-based Barrier
  • Zinc Oxide-based Barrier
  • Silicone-based Barrier
  • Cyanoacrylates-Polymer Film Barrier
  • BCT Agents

By Form

  • Gel
  • Cream
  • Lotion
  • Ointment

By Indication

  • Peristomal Moisture-associated Dermatitis
  • Periwound Moisture-associated Dermatitis
  • Incontinence-associated Dermatitis
  • Intertriginous Dermatitis
  • Immersion Foot (Trench Foot)

By Distribution Channel

  • Retail Pharmacies and Drug Stores
  • Clinics and Hospital Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Moisture-Associated Skin Damage Management Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Growth Outlook
    • 2.3.2. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Key Deals and Mergers
  • 3.4. Comparison of MASD Products Category
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn ) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn ) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn ) Analysis, 2019 - 2023
    • 4.2.2. Current Market Size (US$ Bn ) Analysis and Forecast, 2025 - 2032
  • 4.3. Global Moisture-Associated Skin Damage Management Market Outlook: Product
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn ) Analysis, By Product, 2019 - 2023
    • 4.3.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
      • 4.3.3.1. Petrolatum-based barrier
      • 4.3.3.2. Zinc Oxide-based barrier
      • 4.3.3.3. Silicone-based barrier
      • 4.3.3.4. Cyanoacrylates- Polymer Film Barrier
      • 4.3.3.5. BCT Agents
    • 4.3.4. Market Attractiveness Analysis: Product
  • 4.4. Global Moisture-Associated Skin Damage Management Market Outlook: Form
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn ) Analysis, By Form, 2019 - 2023
    • 4.4.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
      • 4.4.3.1. Gel
      • 4.4.3.2. Cream
      • 4.4.3.3. Lotion
      • 4.4.3.4. Ointment
      • 4.4.3.5. Others
    • 4.4.4.Market Attractiveness Analysis: Form
  • 4.5. Global Moisture-Associated Skin Damage Management Market Outlook: Indication
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn ) Analysis, By Indication, 2019 - 2023
    • 4.5.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
      • 4.5.3.1. Peristomal Moisture-associated Dermatitis
      • 4.5.3.2. Periwound Moisture-associated Dermatitis
      • 4.5.3.3. Incontinence-associated Dermatitis
      • 4.5.3.4. Intertriginous Dermatitis
      • 4.5.3.5. Immersion Foot (Trench Foot)
    • 4.5.4. Market Attractiveness Analysis: Indication
  • 4.6. Global Moisture-Associated Skin Damage Management Market Outlook: Distribution Channel
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Bn ) Analysis, By Distribution Channel, 2019 - 2023
    • 4.6.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      • 4.6.3.1. Retail Pharmacies and Drug Stores
      • 4.6.3.2. Clinics and Hospital Pharmacies
      • 4.6.3.3. Online Pharmacies
    • 4.6.4. Market Attractiveness Analysis: Distribution Channel

5. Global Moisture-Associated Skin Damage Management Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn ) Analysis, By Region, 2019 - 2023
  • 5.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Region, 2025 - 2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 6.2.1. By Country
    • 6.2.2. By Product
    • 6.2.3. By Form
    • 6.2.4. By Indication
    • 6.2.5. By Distribution Channel
  • 6.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 6.4.1. Petrolatum based-barrier
    • 6.4.2. Zinc oxide-based barrier
    • 6.4.3. Silicone based-barrier
    • 6.4.4. Cyanoacrylates- Polymer film barrier
    • 6.4.5. BCT Agents
  • 6.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 6.5.1. Gel
    • 6.5.2. Cream
    • 6.5.3. Lotion
    • 6.5.4. Ointment
    • 6.5.5. Others
  • 6.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 6.6.1. Peristomal Moisture-associated Dermatitis
    • 6.6.2. Periwound moisture-associated Dermatitis
    • 6.6.3. Incontinence-associated Dermatitis
    • 6.6.4. Intertriginous Dermatitis
    • 6.6.5. Immersion foot (trench foot) (IF)
  • 6.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 6.7.1. Retail Pharmacies and Drug Stores
    • 6.7.2. Clinics and Hospital Pharmacies
    • 6.7.3. Online Pharmacies
  • 6.8. Market Attractiveness Analysis

7. Europe Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Form
    • 7.2.4. By Indication
    • 7.2.5. By Distribution Channel
  • 7.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 7.4.1. Petrolatum based-barrier
    • 7.4.2. Zinc oxide-based barrier
    • 7.4.3. Silicone based-barrier
    • 7.4.4. Cyanoacrylates- Polymer film barrier
    • 7.4.5. BCT Agents
  • 7.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 7.5.1. Gel
    • 7.5.2. Cream
    • 7.5.3. Lotion
    • 7.5.4. Ointment
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 7.6.1. Peristomal Moisture-associated Dermatitis
    • 7.6.2. Periwound moisture-associated Dermatitis
    • 7.6.3. Incontinence-associated Dermatitis
    • 7.6.4. Intertriginous Dermatitis
    • 7.6.5. Immersion foot (trench foot) (IF)
  • 7.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 7.7.1. Retail Pharmacies and Drug Stores
    • 7.7.2. Clinics and Hospital Pharmacies
    • 7.7.3. Online Pharmacies
  • 7.8. Market Attractiveness Analysis

8. East Asia Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Form
    • 8.2.4. By Indication
    • 8.2.5. By Distribution Channel
  • 8.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 8.4.1. Petrolatum based-barrier
    • 8.4.2. Zinc oxide-based barrier
    • 8.4.3. Silicone based-barrier
    • 8.4.4. Cyanoacrylates- Polymer film barrier
    • 8.4.5. BCT Agents
  • 8.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 8.5.1. Gel
    • 8.5.2. Cream
    • 8.5.3. Lotion
    • 8.5.4. Ointment
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 8.6.1. Peristomal Moisture-associated Dermatitis
    • 8.6.2. Periwound moisture-associated Dermatitis
    • 8.6.3. Incontinence-associated Dermatitis
    • 8.6.4. Intertriginous Dermatitis
    • 8.6.5. Immersion foot (trench foot) (IF)
  • 8.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 8.7.1. Retail Pharmacies and Drug Stores
    • 8.7.2. Clinics and Hospital Pharmacies
    • 8.7.3. Online Pharmacies
  • 8.8. Market Attractiveness Analysis

9. South Asia & Oceania Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Form
    • 9.2.4. By Indication
    • 9.2.5. By Distribution Channel
  • 9.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 9.4.1. Petrolatum based-barrier
    • 9.4.2. Zinc oxide-based barrier
    • 9.4.3. Silicone based-barrier
    • 9.4.4. Cyanoacrylates- Polymer film barrier
    • 9.4.5. BCT Agents
  • 9.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 9.5.1. Gel
    • 9.5.2. Cream
    • 9.5.3. Lotion
    • 9.5.4. Ointment
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 9.6.1. Peristomal Moisture-associated Dermatitis
    • 9.6.2. Periwound moisture-associated Dermatitis
    • 9.6.3. Incontinence-associated Dermatitis
    • 9.6.4. Intertriginous Dermatitis
    • 9.6.5. Immersion foot (trench foot) (IF)
  • 9.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 9.7.1. Retail Pharmacies and Drug Stores
    • 9.7.2. Clinics and Hospital Pharmacies
    • 9.7.3. Online Pharmacies
  • 9.8. Market Attractiveness Analysis

10. Latin America Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Form
    • 10.2.4. By Indication
    • 10.2.5. By Distribution Channel
  • 10.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 10.4.1. Petrolatum based-barrier
    • 10.4.2. Zinc oxide-based barrier
    • 10.4.3. Silicone based-barrier
    • 10.4.4. Cyanoacrylates- Polymer film barrier
    • 10.4.5. BCT Agents
  • 10.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 10.5.1. Gel
    • 10.5.2. Cream
    • 10.5.3. Lotion
    • 10.5.4. Ointment
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 10.6.1. Peristomal Moisture-associated Dermatitis
    • 10.6.2. Periwound moisture-associated Dermatitis
    • 10.6.3. Incontinence-associated Dermatitis
    • 10.6.4. Intertriginous Dermatitis
    • 10.6.5. Immersion foot (trench foot) (IF)
  • 10.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 10.7.1. Retail Pharmacies and Drug Stores
    • 10.7.2. Clinics and Hospital Pharmacies
    • 10.7.3. Online Pharmacies
  • 10.8. Market Attractiveness Analysis

11. Middle East & Africa Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Form
    • 11.2.4. By Indication
    • 11.2.5. By Distribution Channel
  • 11.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 11.4.1. Petrolatum based-barrier
    • 11.4.2. Zinc oxide-based barrier
    • 11.4.3. Silicone based-barrier
    • 11.4.4. Cyanoacrylates- Polymer film barrier
    • 11.4.5. BCT Agents
  • 11.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 11.5.1. Gel
    • 11.5.2. Cream
    • 11.5.3. Lotion
    • 11.5.4. Ointment
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 11.6.1. Peristomal Moisture-associated Dermatitis
    • 11.6.2. Periwound moisture-associated Dermatitis
    • 11.6.3. Incontinence-associated Dermatitis
    • 11.6.4. Intertriginous Dermatitis
    • 11.6.5. Immersion foot (trench foot) (IF)
  • 11.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 11.7.1. Retail Pharmacies and Drug Stores
    • 11.7.2. Clinics and Hospital Pharmacies
    • 11.7.3. Online Pharmacies
  • 11.8. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. 3M
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Medline Industries, Inc.
    • 12.3.3. Dynarex Corporation
    • 12.3.4. Coloplast Corp.
    • 12.3.5. Wellona Pharma
    • 12.3.6. Cardinal Health
    • 12.3.7. Stryker Sage (Stryker)
    • 12.3.8. DermaRite Industries, LLC.
    • 12.3.9. AMERX Health Care Corp.
    • 12.3.10. Calmoseptine, Inc.
    • 12.3.11. PAUL HARTMANN AG
    • 12.3.12. Smith+Nephew, Inc.
    • 12.3.13. Gentell
    • 12.3.14. UNIFARCO S.p.A.
    • 12.3.15. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations